Journal of Jilin University(Medicine Edition) ›› 2020, Vol. 46 ›› Issue (03): 451-457.doi: 10.13481/j.1671-587x.20200304

• Research in basic medicine • Previous Articles    

Inhibitory effect and apoptosisinduction of MST1R inhibitor BMS-777607 on proliferation of breast cancer MCF-7 cells

KONG Wencong1, HE Wubin2, SU Rongjian3, JIA Daqi1, GU Yanjiao1, WANG Yue1, DU Xiaoyuan1   

  1. 1. Department of Pathology, School of Basic Medical Sciences, Jinzhou Medical University, Jinzhou 121000, China;
    2. First Affiliated Hospital, Jinzhou Medical University, Jinzhou 121001, China;
    3. Department of Cell Biology, School of Basic Medical Sciences, Jinzhou Medical University, Jinzhou 121000, China
  • Received:2019-09-11 Published:2020-06-11

Abstract: Objective: To investigate the effects of macrophage stimulating 1 receptor (MST1R) inhibitor BMS-777607 on the proliferation and apoptosis of the breast cancer MCF-7 cells, and to elucidate the mechanisms. Methods: The breast cancer MCF-7 cells treated with different concentrations of BMS777607 were divided into control group (0μmol·L-1 BMS-777607 group) and 0.5,1.0,2.0,5.0,10.0,15.0,and 20.0μmol·L-1 BMS-777607 groups. MTT method was used to detect the proliferation rates of the MCF-7 cells in various groups, and clone formation assay was used to detect the survival rates of the MCF-7 cells in various groups; EDU imaging and EDU flow cytometry methods were used to detect the proliferation rates of the MCF-7 cells in various groups,and Hoechst33342 staining was used to detect the apoptotic morphology of the MCF-7 cells in various groups; flow cytometry was used to detect the apoptotic rates of the MCF-7 cells in various groups,and Western blotting method was used to detect the expression levels of ERK,p-ERK, Akt,p-Akt, PARP,Cleaved PARP, Bax, Caspase-3,Cleaved Caspase-3,Caspase-9 and Cleaved Caspase-9 proteins in the MCF-7 cells in various groups. Results: The MTT results showed that compared with control group, the proliferation rates of the MCF-7 cells in 5 and 10μmol·L-1 BMS-777607 groups were increased (P<0.05 or P<0.01). The clone formation assay results showed that compared with control group, the survival rates of the MCF-7 cells in 5 and 20μmol·L-1 BMS-777607 groups were increased (P<0.05 or P<0.01).The EDU incorporation results showed that compared with control group, the proliferation rates of the MCF-7 cells in 10 and 20μmol·L-1 BMS-777607 groups were increased (P<0.05 or P<0.01).The Hoechst33342 fluorescence staining results showed that the MCF-7 cells in control group showed the light staining, a small number of MCF-7 cells in 10μmol·L-1 BMS-777607 group showed the bright nuclei,and most of the MCF-7 cells in 20μmol·L-1 BMS-777607 group showed the bright nuclei. The flow cytometry results showed that compared with control group, the apoptotic rates of the MCF-7 cells in 10 and 20μmol·L-1 BMS-777607 groups were decreased (P<0.05). The Western blotting results showed that compared with control group, the expression levels of p-ERK and p-Akt proteins in the MCF-7 cells in 10, 15, and 20μmol·L-1BMS-777607 groups were significantly decreased(P<0.05 or P<0.01), and the expression levels of PARP, Cleaved PARP, Bax, Cleaved Caspase-3, and Cleaved Caspase-9 proteins were significantly increased(P<0.05 or P<0.01). Conclusion: MST1R inhibitor BMS777607 can inhibit the proliferation of MCF-7 cells and induce the apoptosis, and their mechanisms are related to the inhibition of p-ERK and p-Akt expressions and the promotion of expressions of Cleaved PARP, Bax, Cleaved Caspase-9 and Cleaved Caspase-3.

Key words: BMS-777607, breast neoplasms, cell proliferation, apoptosis, macrophage stimulating 1 receptor

CLC Number: 

  • R737.9